Hanall Biopharma (009420) stock
Hanall Biopharma technical analysis
Oscillators
Summary
Moving averages
| Oscillators | Value | Signal |
|---|---|---|
| RSI (14) | 45.53 | Neutral |
| Stochastic %K (14, 3, 3) | 58.44 | Neutral |
| CCI (20) | -29.71 | Neutral |
| ADX (14) | 21.4 | Neutral |
| Awesome Oscillator | -7,698.97 | Neutral |
| Momentum (10) | -350 | Buy |
| MACD (12, 26) | -2,395.19 | Buy |
| Stoch RSI (3, 3, 14, 14) | 89.35 | Neutral |
| Williams %R (14) | -29.55 | Neutral |
| Bull Bear Power | -166.81 | Neutral |
| Ultimate Oscillator (7, 14, 28) | 52.11 | Neutral |
| Moving averages | Value | Signal |
|---|---|---|
| EMA (10) | ₩46,856.21 | Buy |
| SMA (10) | ₩46,015.00 | Buy |
| EMA (20) | ₩48,692.53 | Sell |
| SMA (20) | ₩48,777.50 | Sell |
| EMA (30) | ₩50,062.92 | Sell |
| SMA (30) | ₩52,281.67 | Sell |
| EMA (50) | ₩51,436.58 | Sell |
| SMA (50) | ₩52,247.00 | Sell |
| EMA (100) | ₩52,050.72 | Sell |
| SMA (100) | ₩53,108.00 | Sell |
| EMA (200) | ₩50,048.36 | Sell |
| SMA (200) | ₩52,015.00 | Sell |
| Ichimoku Base Line (9, 26, 52, 26) | ₩53,750.00 | Sell |
| VWMA (20) | ₩48,746.59 | Sell |
| Hull MA (9) | ₩47,191.30 | Buy |
Support & resistance levels
Resistance
- R3₩63,284.45+32.39%Moderate
- R2₩59,700.00+24.90%Weak
- R1₩54,891.27+14.84%Strong
Support
- S1₩41,628.48-12.91%Strong
- S2₩38,224.72-20.03%Moderate
- S3₩32,248.20-32.54%Strong
Levels are detected automatically from swing highs and lows on the daily chart and clustered by volatility (ATR). Strength reflects the number of times price reacted at each level.
| Pivot points (daily) | S3 | S2 | S1 | P | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | ₩41,433.33 | ₩43,466.67 | ₩44,783.33 | ₩46,816.67 | ₩48,133.33 | ₩50,166.67 | ₩51,483.33 |
| Fibonacci | ₩43,466.67 | ₩44,746.37 | ₩45,536.97 | ₩46,816.67 | ₩48,096.37 | ₩48,886.97 | ₩50,166.67 |
| Camarilla | ₩45,178.75 | ₩45,485.83 | ₩45,792.92 | ₩46,816.67 | ₩46,407.08 | ₩46,714.17 | ₩47,021.25 |
| Woodie | ₩41,075.00 | ₩43,287.50 | ₩44,425.00 | ₩46,637.50 | ₩47,775.00 | ₩49,987.50 | ₩51,125.00 |
| DeMark | — | — | ₩44,125.00 | ₩46,487.50 | ₩47,475.00 | — | — |
Hanall Biopharma price forecast
| Horizon | Bear case (95%) | Low (68%) | Trend target | High (68%) | Bull case (95%) |
|---|---|---|---|---|---|
| 5 trading days | ₩36,395.54 | ₩41,651.03 | ₩47,665.42 -0.3% | ₩54,548.27 | ₩62,425.01 |
| 21 trading days | ₩27,176.16 | ₩35,829.15 | ₩47,237.29 -1.2% | ₩62,277.81 | ₩82,107.30 |
| 63 trading days | ₩17,706.76 | ₩28,580.46 | ₩46,131.66 -3.5% | ₩74,461.03 | ₩120,187.40 |
The technical bias for Hanall Biopharma is bearish (overall rating: Sell).
Bullish scenario: a sustained break above ₩54,891.27 would open the way toward ₩59,700.00.
Bearish scenario: a daily close below ₩41,628.48 could extend the decline toward ₩38,224.72.
Statistical ranges are based on historical volatility and trend, not a guarantee of future prices. Not financial advice.
About Hanall Biopharma
Hanall Biopharma (009420) shares are trading at ₩47,800.00, up +3.69% today. The company belongs to the Health Care sector and has a market capitalization of ₩2.43T.
The stock’s 52-week range is ₩30,400.00 – ₩73,000.00, with a price-to-earnings ratio of —. It has moved -1.50% over the past week and -22.13% over the past month.
On the daily chart the overall technical rating for Hanall Biopharma is Sell, with the 14-day RSI at 45.5. The nearest support is at ₩41,628.48 and the nearest resistance at ₩54,891.27.
Related markets
AllStock market news
-
The S&P 500 is back in record territory as the ‘Magnificent Seven’ ride to the rescueMarketWatch.com43 min. ago
-
S&P 500, Nasdaq reach record closing highs as focus pivots to earningsNikkei Asia47 min. ago
-
S&P 500 Notches First Record Close Since AugustBloomberg.com60 min. ago
-
Stock Market Today, Oct. 6: Corteva Rallies 12% on Analyst Upgrade Following Spin OffYahoo Finance1 hr. ago
-
U.S. stocks rise to a record on expectations companies will make even fatter profitsToledo Blade1 hr. ago